February 2011

Pharmaceutical Product Development, Inc. v. TVM Life Science Ventures VI, L.P., C.A. No. 5688-VCS (Del. Ch. Feb. 16, 2011). Read opinion here.

Short Overview
This is a somewhat unremarkable decision involving alleged breaches of contract and fraud–except for its clarification of the distinction between "general damages" and "special damages".

Noteworthy Legal Analysis
The parts of

One of my favorite U.S. Supreme Court Justices is The Hon. Clarence Thomas and his remarks recently at a gathering of law students are words to live by. They are quoted below via The Wall Street Journal’s Law Blog.

“And what I think is important for you all, is that when you see people standing in

The Delaware Court of Chancery’s Guidelines Regarding the Preservation of Electronically Stored Information (ESI) were previously reviewed here on this blog, but now Kevin F. Brady of Connolly Bove Lodge & Hutz LLP in Wilmington, a nationally recognized electronic discovery expert, provides a more comprehensive commentary on the Court’s ESI guidelines, issued last month, in a post

Kevin F. Brady of Connolly Bove Lodge & Hutz, LLP, who was present at many of the lengthy proceedings in this historic case, provides an insider’s perspective in his review of this decision by the Delaware Court of Chancery.

Chancellor William B. Chandler, III upheld the validity of Airgas’s poison pill as an appropriate anti-takeover

David Marcus of The Deal writes here about a recent Chancery hearing involving the sale of Atlas Energy to Chevron, in which the Vice Chancellor reviewing the case sought the disclosure in the proxy statement of more details regarding the interest of key management [a father and son team both named Cohen] in affiliated entities that were also part of